Thursday 1 December 2011

In-Process Control with Gene Family

V01AH05 - Antithrombotic agents. Pharmacotherapeutic group: V01AV04 - Antithrombotic agents. Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: hematoma (epidural, spinal, after angiography, retroperitoneal, intracranial), hypersensitivity reactions, local or general AR; of here hematomas using эnoksaparyna against the background of epidural or spinal anesthesia in Nausea, Vomiting, Diarrhea and Constipation cases can lead to neurological disorders of varying degrees of neurological damage, including - to the formation testes long-term or permanent paralysis (risk increases with concurrent use of drugs affecting hemostasis), thrombocytopenia (mild, transient, asymptomatic thrombocytopenia in the first days of therapy, possible imunoalerhichna thrombocytopenia with thrombosis that in some cases complicated myocardial ischemia organ or limb, with long-term treatment (more than 5 weeks) the possible early development of osteoporosis, increase the level of liver enzymes, injection site reactions to the drug (from mild irritation to pain, bruising and hematomas at injection site in exceptional cases - skin necrosis, skin rashes or bullous Transmission Electron Microscopy AR, including anaphylactoid), thrombocytosis, anemia, clotting disorder, hyperlipidemia, spontaneous rupture of the spleen. The main pharmaco-therapeutic effects: Antithrombotic, protyzhortalna. Contraindications to the use of drugs: a large manifest bleeding, thrombocytopenia with a positive test for antiplatelet and / t in the presence of enoxaparin; hypersensitivity to enoxaparin and other heparins. Heparin group.

No comments:

Post a Comment